Form 4: Select Medical Holdings CEO David Chernow Receives 230,000 Shares of Restricted Stock
SEC Form 4 Filing
David Chernow, President and CEO of Select Medical Holdings, acquired 230,000 shares of restricted stock on April 30, 2024, which will vest in equal annual installments over three years.
Summary
- On April 30, 2024, David Chernow, the President and CEO of Select Medical Holdings, acquired 230,000 shares of common stock.
- These shares were granted as restricted stock and will vest in equal annual installments over three years.
- Following the transaction, Chernow beneficially owns 1,172,250 shares of Select Medical Holdings.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and aligns management with shareholder interests.
Positives
- The grant of restricted stock aligns the CEO's interests with the long-term performance of the company.
Future Outlook
The restricted stock will vest in equal annual installments over three years, suggesting a commitment to the company's future performance.
Industry Context
Grants of restricted stock are a common form of executive compensation in the healthcare industry, aligning management's interests with shareholder value.
Stakeholder Impact
- The grant of restricted stock aligns the CEO's interests with those of the shareholders, potentially driving long-term value creation.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Date of transaction: David Chernow acquired 230,000 shares of restricted stock. |
| 05/01/2024 | Date of filing: Form 4 filing date. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.